DE60039508D1 - Methoden zur behandlung der essstörungen - Google Patents
Methoden zur behandlung der essstörungenInfo
- Publication number
- DE60039508D1 DE60039508D1 DE60039508T DE60039508T DE60039508D1 DE 60039508 D1 DE60039508 D1 DE 60039508D1 DE 60039508 T DE60039508 T DE 60039508T DE 60039508 T DE60039508 T DE 60039508T DE 60039508 D1 DE60039508 D1 DE 60039508D1
- Authority
- DE
- Germany
- Prior art keywords
- treating
- treatments
- methods
- nervosa
- snacking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12515099P | 1999-03-19 | 1999-03-19 | |
PCT/US2000/007115 WO2000054765A1 (en) | 1999-03-19 | 2000-03-17 | Method of treating eating disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60039508D1 true DE60039508D1 (de) | 2008-08-28 |
Family
ID=22418412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60039508T Expired - Lifetime DE60039508D1 (de) | 1999-03-19 | 2000-03-17 | Methoden zur behandlung der essstörungen |
Country Status (23)
Country | Link |
---|---|
US (1) | US6365633B1 (de) |
EP (1) | EP1178789B1 (de) |
JP (1) | JP2003519087A (de) |
KR (1) | KR100432825B1 (de) |
CN (1) | CN1188120C (de) |
AT (1) | ATE401066T1 (de) |
AU (1) | AU773188C (de) |
BR (1) | BR0009026A (de) |
CA (1) | CA2367666C (de) |
CZ (1) | CZ20013278A3 (de) |
DE (1) | DE60039508D1 (de) |
ES (1) | ES2307501T3 (de) |
HK (1) | HK1045455B (de) |
HU (1) | HUP0200495A3 (de) |
IL (1) | IL145240A (de) |
MX (1) | MXPA01009404A (de) |
NO (1) | NO20014479L (de) |
NZ (1) | NZ514011A (de) |
PL (1) | PL351963A1 (de) |
SK (1) | SK12992001A3 (de) |
TR (1) | TR200102646T2 (de) |
WO (1) | WO2000054765A1 (de) |
ZA (1) | ZA200107533B (de) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020006963A1 (en) * | 1992-06-23 | 2002-01-17 | Young James W. | Method of using and compositions comprising (-) sibutramine optionally in combination with other pharmacologically active compounds |
US20020006964A1 (en) * | 1995-05-16 | 2002-01-17 | Young James W. | Methods of using and compositions comprising (+) sibutramine optionally in combination with other pharmacologically active compounds |
US6974838B2 (en) | 1998-08-24 | 2005-12-13 | Sepracor Inc. | Methods of treating or preventing pain using sibutramine metabolites |
US6476078B2 (en) | 1999-08-11 | 2002-11-05 | Sepracor, Inc. | Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction |
US6399826B1 (en) | 1999-08-11 | 2002-06-04 | Sepracor Inc. | Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
WO2002083631A1 (en) | 2001-04-13 | 2002-10-24 | Sepracor Inc. | Methods of preparing didesmethylsibutramine and other sibutramine derivatives |
US7105526B2 (en) | 2002-06-28 | 2006-09-12 | Banyu Pharmaceuticals Co., Ltd. | Benzimidazole derivatives |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
US20050131074A1 (en) * | 2003-08-04 | 2005-06-16 | Beckman Kristen M. | Methods for treating metabolic syndrome |
WO2005028438A1 (ja) | 2003-09-22 | 2005-03-31 | Banyu Pharmaceutical Co., Ltd. | 新規ピペリジン誘導体 |
WO2005097127A2 (en) | 2004-04-02 | 2005-10-20 | Merck & Co., Inc. | Method of treating men with metabolic and anthropometric disorders |
CA2577060A1 (en) * | 2004-08-13 | 2006-02-23 | Amgen Inc. | Substituted benzofused heterocycles |
US8394765B2 (en) * | 2004-11-01 | 2013-03-12 | Amylin Pharmaceuticals Llc | Methods of treating obesity with two different anti-obesity agents |
CN101094689B (zh) | 2004-11-01 | 2013-06-12 | 安米林药品有限责任公司 | 治疗肥胖以及肥胖相关疾病和病症的方法 |
US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
US8138206B2 (en) | 2005-05-30 | 2012-03-20 | Msd. K.K. | Piperidine derivative |
JPWO2007018248A1 (ja) | 2005-08-10 | 2009-02-19 | 萬有製薬株式会社 | ピリドン化合物 |
BRPI0614649A2 (pt) | 2005-08-11 | 2011-04-12 | Amylin Pharmaceuticals Inc | polipeptìdeos hìbridos com propriedades selecionáveis |
EP1922336B1 (de) | 2005-08-11 | 2012-11-21 | Amylin Pharmaceuticals, LLC | Hybridpolypeptide mit auswählbaren eigenschaften |
DE602006017712D1 (de) | 2005-08-24 | 2010-12-02 | Banyu Pharma Co Ltd | Phenylpyridonderivat |
US20090264426A1 (en) | 2005-09-07 | 2009-10-22 | Shunji Sakuraba | Bicyclic aromatic substituted pyridone derivative |
EP1938811A4 (de) * | 2005-09-22 | 2008-12-17 | Eisai R&D Man Co Ltd | Medizinische zusammensetzung zur behandlung von bulimie und mit bulimie einhergehenden depressionen |
CA2624030A1 (en) | 2005-09-29 | 2007-04-12 | Tianying Jian | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
EP2332526A3 (de) | 2005-10-21 | 2011-10-12 | Novartis AG | Kombination eines Renin-Inhibitors mit einem anti-dyslipidämischen Wirkstoff oder einem Wirkstoff gegen Adipositas |
CA2627139A1 (en) | 2005-10-27 | 2007-05-03 | Banyu Pharmaceutical Co., Ltd. | Novel benzoxathiin derivative |
EP1953165B1 (de) | 2005-11-10 | 2012-02-01 | Msd K.K. | Aza-substituierte spiroderivate |
CA2664113C (en) | 2006-09-22 | 2013-05-28 | Merck & Co., Inc. | Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer |
EP2072519A4 (de) | 2006-09-28 | 2009-10-21 | Banyu Pharma Co Ltd | Diarylketiminderivat |
US8431552B2 (en) | 2007-01-16 | 2013-04-30 | Chien-Hung Chen | Composition for treating metabolic syndrome |
WO2008120653A1 (ja) | 2007-04-02 | 2008-10-09 | Banyu Pharmaceutical Co., Ltd. | インドールジオン誘導体 |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
EP2998314B1 (de) | 2007-06-04 | 2020-01-22 | Bausch Health Ireland Limited | Für die behandlung von gastrointestinalen erkrankungen, entzündungen, krebs und anderen erkrankungen geeignete agonisten von guanylatcyclase |
EP2219664A1 (de) * | 2007-11-14 | 2010-08-25 | Amylin Pharmaceuticals, Inc. | Verfahren zur behandlung von fettsucht und erkrankungen und störungen im zusammenhang mit fettsucht |
EP2264026A4 (de) | 2008-03-06 | 2012-03-28 | Msd Kk | Alkylaminopyridinderivate |
CN101981025A (zh) | 2008-03-28 | 2011-02-23 | 万有制药株式会社 | 具有黑色素浓缩激素受体拮抗作用的二芳基甲基酰胺衍生物 |
CA2666036C (en) | 2008-05-16 | 2017-09-12 | Chien-Hung Chen | Novel compositions and methods for treating hyperproliferative diseases |
WO2009149279A2 (en) | 2008-06-04 | 2009-12-10 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
EP2301936A1 (de) | 2008-06-19 | 2011-03-30 | Banyu Pharmaceutical Co., Ltd. | Spirodiamin-diarylketoximid-derivat |
WO2010009319A2 (en) | 2008-07-16 | 2010-01-21 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
US20110124674A1 (en) | 2008-07-30 | 2011-05-26 | Hiroyuki Kishino | 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
CN102264228A (zh) | 2008-10-22 | 2011-11-30 | 默沙东公司 | 用于抗糖尿病药的新的环状苯并咪唑衍生物 |
JP5557845B2 (ja) | 2008-10-31 | 2014-07-23 | メルク・シャープ・アンド・ドーム・コーポレーション | 糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体 |
EP2379562A1 (de) | 2008-12-16 | 2011-10-26 | Schering Corporation | Bicyclische pyranonderivate als agonisten am nicotinsäurerezeptor |
EP2379547A1 (de) | 2008-12-16 | 2011-10-26 | Schering Corporation | Pyridopyrimidinderivate und verfahren zu deren anwendung |
US8895596B2 (en) | 2010-02-25 | 2014-11-25 | Merck Sharp & Dohme Corp | Cyclic benzimidazole derivatives useful as anti-diabetic agents |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CN103476258B (zh) | 2011-02-25 | 2017-04-26 | 默沙东公司 | 用作抗糖尿病药剂的新的环状氮杂苯并咪唑衍生物 |
WO2014022528A1 (en) | 2012-08-02 | 2014-02-06 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
RU2015140066A (ru) | 2013-02-22 | 2017-03-30 | Мерк Шарп И Доум Корп. | Противодиабетические бициклические соединения |
EP2970119B1 (de) | 2013-03-14 | 2021-11-03 | Merck Sharp & Dohme Corp. | Neuartige indolderivate als antidiabetika |
US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
KR102272746B1 (ko) | 2013-06-05 | 2021-07-08 | 보슈 헬스 아일랜드 리미티드 | 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법 |
WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
US9708272B2 (en) | 2014-08-29 | 2017-07-18 | Tes Pharma S.R.L. | Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylase |
RU2019114228A (ru) | 2016-10-14 | 2020-11-16 | Тес Фарма С.Р.Л. | ИНГИБИТОРЫ ДЕКАРБОКСИЛАЗЫ ПОЛУАЛЬДЕГИДА α-АМИНО-β-КАРБОКСИМУКОНОВОЙ КИСЛОТЫ |
US11072602B2 (en) | 2016-12-06 | 2021-07-27 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
EP3558298A4 (de) | 2016-12-20 | 2020-08-05 | Merck Sharp & Dohme Corp. | Antidiabetische spirochromanverbindungen |
KR20210111248A (ko) | 2018-11-20 | 2021-09-10 | 테스 파마 에스.알.엘. | α-아미노-β-카르복시뮤콘산 세미알데하이드 데카르복실라제의 저해제 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2675573B2 (ja) * | 1988-03-31 | 1997-11-12 | 科研製薬株式会社 | 脳機能改善剤 |
IE61928B1 (en) * | 1988-11-29 | 1994-11-30 | Boots Co Plc | Treatment of obesity |
US5356934A (en) * | 1990-03-29 | 1994-10-18 | Eli Lilly And Company | Selected serotonin subtype receptor agonist to treat sleep apnea |
JP2001524960A (ja) * | 1997-04-24 | 2001-12-04 | メルク シヤープ エンド ドーム リミテツド | 摂食障害を治療するためのnk−1受容体拮抗薬の使用 |
US6331571B1 (en) * | 1998-08-24 | 2001-12-18 | Sepracor, Inc. | Methods of treating and preventing attention deficit disorders |
KR20010111254A (ko) * | 1999-01-20 | 2001-12-17 | 토마스 와이. 올맨 | 금연 보조 방법 |
WO2000050020A2 (en) * | 1999-02-24 | 2000-08-31 | University Of Cincinnati | Use of sulfamate derivatives for treating impulse control disorders |
-
2000
- 2000-03-17 AU AU38947/00A patent/AU773188C/en not_active Ceased
- 2000-03-17 ES ES00918073T patent/ES2307501T3/es not_active Expired - Lifetime
- 2000-03-17 JP JP2000604841A patent/JP2003519087A/ja active Pending
- 2000-03-17 HU HU0200495A patent/HUP0200495A3/hu unknown
- 2000-03-17 CN CNB008074321A patent/CN1188120C/zh not_active Expired - Fee Related
- 2000-03-17 IL IL145240A patent/IL145240A/en not_active IP Right Cessation
- 2000-03-17 BR BR0009026-3A patent/BR0009026A/pt not_active Application Discontinuation
- 2000-03-17 MX MXPA01009404A patent/MXPA01009404A/es unknown
- 2000-03-17 KR KR10-2001-7011781A patent/KR100432825B1/ko not_active IP Right Cessation
- 2000-03-17 NZ NZ514011A patent/NZ514011A/en not_active IP Right Cessation
- 2000-03-17 US US09/528,355 patent/US6365633B1/en not_active Expired - Fee Related
- 2000-03-17 CZ CZ20013278A patent/CZ20013278A3/cs unknown
- 2000-03-17 PL PL00351963A patent/PL351963A1/xx not_active Application Discontinuation
- 2000-03-17 TR TR2001/02646T patent/TR200102646T2/xx unknown
- 2000-03-17 SK SK1299-2001A patent/SK12992001A3/sk unknown
- 2000-03-17 EP EP00918073A patent/EP1178789B1/de not_active Expired - Lifetime
- 2000-03-17 CA CA002367666A patent/CA2367666C/en not_active Expired - Fee Related
- 2000-03-17 AT AT00918073T patent/ATE401066T1/de not_active IP Right Cessation
- 2000-03-17 WO PCT/US2000/007115 patent/WO2000054765A1/en active IP Right Grant
- 2000-03-17 DE DE60039508T patent/DE60039508D1/de not_active Expired - Lifetime
-
2001
- 2001-09-12 ZA ZA200107533A patent/ZA200107533B/xx unknown
- 2001-09-14 NO NO20014479A patent/NO20014479L/no not_active Application Discontinuation
-
2002
- 2002-07-17 HK HK02105308.4A patent/HK1045455B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ514011A (en) | 2001-09-28 |
CN1365276A (zh) | 2002-08-21 |
CN1188120C (zh) | 2005-02-09 |
MXPA01009404A (es) | 2004-03-19 |
AU773188C (en) | 2006-01-05 |
IL145240A0 (en) | 2002-06-30 |
ATE401066T1 (de) | 2008-08-15 |
ES2307501T3 (es) | 2008-12-01 |
TR200102646T2 (tr) | 2002-08-21 |
ZA200107533B (en) | 2002-12-12 |
BR0009026A (pt) | 2003-03-05 |
EP1178789B1 (de) | 2008-07-16 |
AU773188B2 (en) | 2004-05-20 |
SK12992001A3 (sk) | 2002-03-05 |
KR20020063107A (ko) | 2002-08-01 |
NO20014479D0 (no) | 2001-09-14 |
KR100432825B1 (ko) | 2004-05-24 |
IL145240A (en) | 2007-02-11 |
EP1178789A4 (de) | 2004-02-18 |
HUP0200495A3 (en) | 2004-09-28 |
NO20014479L (no) | 2001-11-02 |
HK1045455B (zh) | 2009-04-09 |
HUP0200495A2 (en) | 2002-08-28 |
AU3894700A (en) | 2000-10-04 |
JP2003519087A (ja) | 2003-06-17 |
WO2000054765A8 (en) | 2002-05-23 |
CZ20013278A3 (cs) | 2002-07-17 |
EP1178789A1 (de) | 2002-02-13 |
PL351963A1 (en) | 2003-07-14 |
HK1045455A1 (en) | 2002-11-29 |
US6365633B1 (en) | 2002-04-02 |
CA2367666A1 (en) | 2000-09-21 |
WO2000054765A1 (en) | 2000-09-21 |
CA2367666C (en) | 2008-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60039508D1 (de) | Methoden zur behandlung der essstörungen | |
NO20021328L (no) | Pyrazolopyrimidier som terapeutiske midler | |
DE60210944D1 (de) | N-substituierte heterocyclische nichtaryl-nmda/nr2b-antagonisten | |
DE60331187D1 (de) | Kinaseinhibitoren | |
MXPA03003912A (es) | Tratamientos nuevos para el sindrome de piernas inquietas. | |
NO20050666L (no) | 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer | |
PE20060355A1 (es) | TIENO[3,2-b]PIRIDIN-6-CARBONITRILOS COMO INHIBIDORES DE LA QUINASA PROTEICA | |
TR200201205T2 (tr) | N-ikame edilmiş karbamoiloksialkil-azolyum türevleri. | |
ATE308522T1 (de) | Opioidrezeptorantagonisten | |
BRPI0407841A (pt) | inibidores heterocìclicos de quinase | |
WO2000056315A8 (en) | Treatment of pain | |
DK1169029T3 (da) | Anvendelse af sibutramin eller et derivat deraf til behandling af sövnforstyrrelser | |
SE0103795D0 (sv) | Compounds and method for the treatment of överactive bladder | |
ATE440835T1 (de) | Heterozyklische harnstoff-derivate für die behandlung von schmerzen. | |
NO20063299L (no) | Syntese av en polymorf av 4-amino-5-klor-2-metoksy-N-(1-azabisyklo[3.3.1]non-4-yl)benzamidhydrokloridhydrat | |
BG105996A (en) | Method of treating eating disorders | |
MXPA01009461A (es) | Tratamiento de osteoartritis. | |
MXPA01009469A (es) | Tratamiento para disminuir la adhesividad de las plaquetas. | |
MXPA01009468A (es) | Tratamiento de hipertension pulmonar. | |
SE0103668D0 (sv) | Method for the treatment of overactive blader | |
MXPA01009463A (es) | Tratamiento de hernia hiatial. | |
DE60208347D1 (de) | Verwendung von "xylyloxy alkyl amines" für die Behandlung von Tinnitus | |
MXPA01009465A (es) | Perdida de peso despues del embarazo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent |